These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6170889)

  • 41. Severe anaphylactic reaction to human insulin in a diabetic patient.
    Kaya A; Gungor K; Karakose S
    J Diabetes Complications; 2007; 21(2):124-7. PubMed ID: 17331861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Insulin resistance caused by an increase in proteolytic enzyme activity at the site of insulin injection. Study in insulin-dependent diabetic subjects].
    Calle Pascual AL; Marañes Pallardó JP; Charro Salgado AL
    Med Clin (Barc); 1983 Apr; 80(12):524-6. PubMed ID: 6191160
    [No Abstract]   [Full Text] [Related]  

  • 43. [Insulin injector pens in the treatment of diabetes mellitus].
    Costa B
    Med Clin (Barc); 1990 Oct; 95(11):430-4. PubMed ID: 2082115
    [No Abstract]   [Full Text] [Related]  

  • 44. [Multiple insulin injections with the help of a subcutaneous catheter or metered syringe (Pen)].
    Tatoń J; Czech A; Jagielińska-Kalinowska E
    Pol Tyg Lek; 1991 Oct 28-Nov 4; 46(43-44):834-7. PubMed ID: 1669173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anaphylaxis from aprotinin re-exposure during heart transplantation.
    Toleva O; Cheung A; Ignaszewski A
    J Heart Lung Transplant; 2007 Sep; 26(9):962-3. PubMed ID: 17845939
    [No Abstract]   [Full Text] [Related]  

  • 46. Extreme subcutaneous insulin resistance successfully treated by an implantable pump.
    Riveline JP; Capeau J; Robert JJ; Varroud-Vial M; Cerf-Baron I; Deburge A; Charpentier G
    Diabetes Care; 2001 Dec; 24(12):2155-6. PubMed ID: 11723102
    [No Abstract]   [Full Text] [Related]  

  • 47. Diabetes and hypertension.
    Lowy C
    Lancet; 1978 Aug; 2(8086):429-30. PubMed ID: 79792
    [No Abstract]   [Full Text] [Related]  

  • 48. Subcutaneous-insulin-resistance syndrome.
    N Engl J Med; 1987 Jan; 316(1):49-51. PubMed ID: 3537795
    [No Abstract]   [Full Text] [Related]  

  • 49. Subcutaneous aprotinin causes local hyperaemia. A possible mechanism by which aprotinin improves control in some diabetic patients.
    Williams G; Pickup JC; Bowcock S; Cooke E; Keen H
    Diabetologia; 1983 Feb; 24(2):91-4. PubMed ID: 6188643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin delivery devices.
    Felig P; Tamborlane WV
    Ann Intern Med; 1980 Oct; 93(4):627-9. PubMed ID: 7001977
    [No Abstract]   [Full Text] [Related]  

  • 51. Lipohypertrophy and glomerulonephritis after the use of aprotinin in an insulin-dependent diabetic.
    Boag F; Chappell M; Beckett AG; Dandona P
    N Engl J Med; 1985 Jan; 312(4):245-6. PubMed ID: 2578215
    [No Abstract]   [Full Text] [Related]  

  • 52. Insulin via continuous subcutaneous infusion.
    Pickup JC; Keen H; Stevenson RW; Parsons JA; Alberti KG; White M; Kohner EM
    Lancet; 1978 Nov; 2(8097):988-9. PubMed ID: 82007
    [No Abstract]   [Full Text] [Related]  

  • 53. [Insulin and the giving of insulin injections].
    Schmidt T
    Krankenpflege (Frankf); 1985; 39(7-8):247-9. PubMed ID: 3932760
    [No Abstract]   [Full Text] [Related]  

  • 54. Evidence for insulin degradation by muscle and fat tissue in an insulin resistant diabetic patient.
    Maberly GF; Wait GA; Kilpatrick JA; Loten EG; Gain KR; Stewart RD; Eastman CJ
    Diabetologia; 1982 Oct; 23(4):333-6. PubMed ID: 6183163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison on intravenous and subcutaneous insulin infusions in man.
    Katsilambros N; Verykokidou H; Philipides P; Moiras G; Daikos GK
    Lancet; 1979 Mar; 1(8116):609-10. PubMed ID: 85192
    [No Abstract]   [Full Text] [Related]  

  • 56. Anaphylactic reaction to aprotinin.
    Ong BC; Tan SS; Tan YS
    Anaesth Intensive Care; 1999 Oct; 27(5):538. PubMed ID: 10520400
    [No Abstract]   [Full Text] [Related]  

  • 57. Subcutaneous injections and absorption of insulin.
    Lancet; 1980 May; 1(8176):1005-6. PubMed ID: 6103328
    [No Abstract]   [Full Text] [Related]  

  • 58. Low-dose insulin infusions in diabetic patients with high insulin requirements.
    Dandona P
    Lancet; 1978 Sep; 2(8090):637. PubMed ID: 80567
    [No Abstract]   [Full Text] [Related]  

  • 59. [Insulin used to control diabetes (author's transl)].
    Lu MS
    Hu Li Za Zhi; 1981 Jan; 28(1):45-51. PubMed ID: 7017082
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter: Anaphylactic reaction to aprotinin.
    Proud G; Chamberlain J
    Lancet; 1976 Jul; 2(7975):48-9. PubMed ID: 59117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.